# Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis

> **NCT05167760** · PHASE4 · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Synkinesis
- Facial Nerve Palsy

## Interventions

- **DRUG:** Apraclonidine

## Key facts

- **NCT ID:** NCT05167760
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-12
- **Primary completion:** 2027-11
- **Final completion:** 2028-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The project never opened.
- **Last updated:** 2024-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05167760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05167760, "Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05167760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*